CovidChloroV1, Main, Corpus, bibRecord, 001985

Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity.

Identifieur interne : 001985 ( Main/Corpus ); précédent : 001984; suivant : 001986

Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity.

Auteurs : Jerry L. Bauman ; James E. Tisdale

Source :

Pharmacotherapy [ 1875-9114 ] ; 2020.

RBID : pubmed:32285489

English descriptors

KwdEn :
- COVID-19 (drug therapy), Cardiotoxicity (MeSH), Chloroquine (pharmacokinetics), Chloroquine (therapeutic use), Chloroquine (toxicity), Humans (MeSH), Hydroxychloroquine (pharmacokinetics), Hydroxychloroquine (therapeutic use), Hydroxychloroquine (toxicity), Risk Factors (MeSH), SARS-CoV-2 (MeSH), Torsades de Pointes (chemically induced).
MESH :
- chemical , pharmacokinetics : Chloroquine, Hydroxychloroquine.
- chemically induced : Torsades de Pointes.
- drug therapy : COVID-19.
- chemical , therapeutic use : Chloroquine, Hydroxychloroquine.
- chemical , toxicity : Chloroquine, Hydroxychloroquine.
- Cardiotoxicity, Humans, Risk Factors, SARS-CoV-2.

DOI: 10.1002/phar.2387
PubMed: 32285489

Links to Exploration step

pubmed:32285489

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity.</title>
<author><name sortKey="Bauman, Jerry L" sort="Bauman, Jerry L" uniqKey="Bauman J" first="Jerry L" last="Bauman">Jerry L. Bauman</name>
<affiliation><nlm:affiliation>Pharmacotherapy Publications and University of Illinois College of Pharmacy, Chicago, Illinois.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tisdale, James E" sort="Tisdale, James E" uniqKey="Tisdale J" first="James E" last="Tisdale">James E. Tisdale</name>
<affiliation><nlm:affiliation>Purdue University College of Pharmacy and Indiana University School of Medicine, Indianapolis, Indiana.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32285489</idno>
<idno type="pmid">32285489</idno>
<idno type="doi">10.1002/phar.2387</idno>
<idno type="wicri:Area/Main/Corpus">001985</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001985</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity.</title>
<author><name sortKey="Bauman, Jerry L" sort="Bauman, Jerry L" uniqKey="Bauman J" first="Jerry L" last="Bauman">Jerry L. Bauman</name>
<affiliation><nlm:affiliation>Pharmacotherapy Publications and University of Illinois College of Pharmacy, Chicago, Illinois.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tisdale, James E" sort="Tisdale, James E" uniqKey="Tisdale J" first="James E" last="Tisdale">James E. Tisdale</name>
<affiliation><nlm:affiliation>Purdue University College of Pharmacy and Indiana University School of Medicine, Indianapolis, Indiana.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Pharmacotherapy</title>
<idno type="eISSN">1875-9114</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COVID-19 (drug therapy)</term>
<term>Cardiotoxicity (MeSH)</term>
<term>Chloroquine (pharmacokinetics)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Chloroquine (toxicity)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (pharmacokinetics)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Hydroxychloroquine (toxicity)</term>
<term>Risk Factors (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Torsades de Pointes (chemically induced)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Torsades de Pointes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="toxicity" xml:lang="en"><term>Chloroquine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cardiotoxicity</term>
<term>Humans</term>
<term>Risk Factors</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32285489</PMID>
<DateCompleted><Year>2021</Year>
<Month>03</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>03</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-9114</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>40</Volume>
<Issue>5</Issue>
<PubDate><Year>2020</Year>
<Month>05</Month>
</PubDate>
</JournalIssue>
<Title>Pharmacotherapy</Title>
<ISOAbbreviation>Pharmacotherapy</ISOAbbreviation>
</Journal>
<ArticleTitle>Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity.</ArticleTitle>
<Pagination><MedlinePgn>387-388</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/phar.2387</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bauman</LastName>
<ForeName>Jerry L</ForeName>
<Initials>JL</Initials>
<Identifier Source="ORCID">0000-0001-6265-8180</Identifier>
<AffiliationInfo><Affiliation>Pharmacotherapy Publications and University of Illinois College of Pharmacy, Chicago, Illinois.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tisdale</LastName>
<ForeName>James E</ForeName>
<Initials>JE</Initials>
<Identifier Source="ORCID">0000-0002-2117-9463</Identifier>
<AffiliationInfo><Affiliation>Purdue University College of Pharmacy and Indiana University School of Medicine, Indianapolis, Indiana.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Pharmacotherapy</MedlineTA>
<NlmUniqueID>8111305</NlmUniqueID>
<ISSNLinking>0277-0008</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D066126" MajorTopicYN="Y">Cardiotoxicity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016171" MajorTopicYN="N">Torsades de Pointes</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32285489</ArticleId>
<ArticleId IdType="doi">10.1002/phar.2387</ArticleId>
</ArticleIdList>
<ReferenceList><Title>References</Title>
<Reference><Citation>Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020; In press. https://doi.org/10.1016/j.ijantimicag.2020.105949</Citation>
</Reference>
<Reference><Citation>Ben-Zvi I, Kivitny S, Langevitz P, Shoenfeld Y. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol 2012;42:145-53.</Citation>
</Reference>
<Reference><Citation>Al-Bari MMA. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother 2015;70:1608-621.</Citation>
</Reference>
<Reference><Citation>Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmolol. 2014;132(12):1453-60.</Citation>
</Reference>
<Reference><Citation>Chen CY, Wang FL, Lin CC. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol 2006;44:173-75.</Citation>
</Reference>
<Reference><Citation>O’Laughlin JP, Mehta PH, Wong BC. Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine. Case Rep Cardiol 2016;2016:1-4; Article ID 4626279.</Citation>
</Reference>
<Reference><Citation>Woosley RL, Heise CW, Gallo T, Tate J, Woosley D, Romero KA. www.CredibleMeds.org, QTdrugs List, [accessed March 22, 2020], AZCERT, Inc. 1822 Innovation Park Dr., Oro Valley, AZ 85755.</Citation>
</Reference>
<Reference><Citation>Bauman JL, Bauernfeind RA, Hoff JV, Strasberg B, Swiryn S, Rosen KM. Torsades de pointes due to quinidine: observations in 31 patients. Am Heart J 1984;107:425-30.</Citation>
</Reference>
<Reference><Citation>Radke JB, Kingery JM, Maakestad J, Krasawski MD. Diagnostic pitfalls and laboratory test interference after hydroxychloroquine intoxication: a case report. Toxicol Rep 2019;6:1040-46.</Citation>
</Reference>
<Reference><Citation>De Olano J, Howland MA, Su MK, Hoffman RS, Biary R. Toxicokinetics of hydroxychloroquine following a massive overdose. Am J Emerg Med 2019;37: 2264.e5-e8.</Citation>
</Reference>
<Reference><Citation>Demaziere J, Fourcade JM, Busseuil CT, Adeleine P, Meyer SM, Saissy JM. The hazards of chloroquine self prescription in west Africa. J Toxicol Clin Toxicol 1995;33:369-70.</Citation>
</Reference>
<Reference><Citation>Tett SE. Clinical pharmacokinetics of slow-acting antirheumatic drugs. Clin Pharmacokinet 1993;25:392-407.</Citation>
</Reference>
<Reference><Citation>Furst DE. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic disease. Lupus 1996;5:S11-15.</Citation>
</Reference>
<Reference><Citation>Tisdale JE, Jaynes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 2013;6:479-87.</Citation>
</Reference>
<Reference><Citation>Woosley RL. Cardiac complications of chloroquine-based therapy. Cardiology 2020 (In press).</Citation>
</Reference>
<Reference><Citation>Trinkley KE, Page RL 2nd, Lien H, Yamanouye K, Tisdale JE. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Cur Med Res Opin 2013;29:1719-26.</Citation>
</Reference>
<Reference><Citation>Giudicessi JR, Nosweworthy PA, Friedman PA, Ackerman MJ. Urgent guidance for navigating and circumventing the QTc prolongation and torsadogenic potential for possible pharmacotherapies for COVID-19. Mayo Clin Proc 2020;95: In press.</Citation>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001985 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001985 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32285489
   |texte=   Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32285489" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity.

Chloroquine and Hydroxychloroquine in the Era of SARS - CoV2: Caution on Their Cardiac Toxicity.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki